147 related articles for article (PubMed ID: 16061909)
21. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
22. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
Bange J; Prechtl D; Cheburkin Y; Specht K; Harbeck N; Schmitt M; Knyazeva T; Müller S; Gärtner S; Sures I; Wang H; Imyanitov E; Häring HU; Knayzev P; Iacobelli S; Höfler H; Ullrich A
Cancer Res; 2002 Feb; 62(3):840-7. PubMed ID: 11830541
[TBL] [Abstract][Full Text] [Related]
23. Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension.
Al-Daghri NM; Mohammed AK; Al-Attas OS; Draz HM; Alokail MS
Genet Test Mol Biomarkers; 2017 Jul; 21(7):422-427. PubMed ID: 28650667
[TBL] [Abstract][Full Text] [Related]
24. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
Wang YC; Chen CY; Chen SK; Chang YY; Lin P
Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
[TBL] [Abstract][Full Text] [Related]
25. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
27. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
[TBL] [Abstract][Full Text] [Related]
28. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
[TBL] [Abstract][Full Text] [Related]
29. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M
BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172
[TBL] [Abstract][Full Text] [Related]
30. Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke.
Zhang HF; Zhao KJ; Yang PF; Fang YB; Zhang YH; Liu JM; Huang QH
J Int Med Res; 2012; 40(5):1708-14. PubMed ID: 23206452
[TBL] [Abstract][Full Text] [Related]
31. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
Ye YW; Zhou Y; Yuan L; Wang CM; Du CY; Zhou XY; Zheng BQ; Cao X; Sun MH; Fu H; Shi YQ
Cancer; 2011 Dec; 117(23):5304-13. PubMed ID: 21567388
[TBL] [Abstract][Full Text] [Related]
33. Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas.
Mawrin C; Kirches E; Diete S; Wiedemann FR; Schneider T; Firsching R; Kropf S; Bogerts B; Vorwerk CK; Krüger S; Dietzmann K
Cancer Lett; 2006 Aug; 239(2):239-45. PubMed ID: 16198476
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
Ho HK; Pok S; Streit S; Ruhe JE; Hart S; Lim KS; Loo HL; Aung MO; Lim SG; Ullrich A
J Hepatol; 2009 Jan; 50(1):118-27. PubMed ID: 19008009
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in TGF-beta1 gene and the risk of lung cancer.
Kang HG; Chae MH; Park JM; Kim EJ; Park JH; Kam S; Cha SI; Kim CH; Park RW; Park SH; Kim YL; Kim IS; Jung TH; Park JY
Lung Cancer; 2006 Apr; 52(1):1-7. PubMed ID: 16499994
[TBL] [Abstract][Full Text] [Related]
36. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor-1α polymorphisms are associated with genetic aberrations in lung cancer.
Putra AC; Tanimoto K; Arifin M; Hiyama K
Respirology; 2011 Jul; 16(5):796-802. PubMed ID: 21435097
[TBL] [Abstract][Full Text] [Related]
38. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
40. Functional regulatory variants of MCL1 contribute to enhanced promoter activity and reduced risk of lung cancer in nonsmokers: implications for context-dependent phenotype of an antiapoptotic and antiproliferative gene in solid tumor.
Jiang Y; Wang W; Wang J; Lu Y; Chen Y; Jin L; Lin D; He F; Wang H
Cancer; 2012 Apr; 118(8):2085-95. PubMed ID: 21887682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
